BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 21637838)

  • 1. Identification of novel targets of CSL-dependent Notch signaling in hematopoiesis.
    Hamidi H; Gustafason D; Pellegrini M; Gasson J
    PLoS One; 2011; 6(5):e20022. PubMed ID: 21637838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down regulation of CSL activity inhibits cell proliferation in prostate and breast cancer cells.
    Yong T; Sun A; Henry MD; Meyers S; Davis JN
    J Cell Biochem; 2011 Sep; 112(9):2340-51. PubMed ID: 21520243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOTCH1 and NOTCH3 coordinate esophageal squamous differentiation through a CSL-dependent transcriptional network.
    Ohashi S; Natsuizaka M; Yashiro-Ohtani Y; Kalman RA; Nakagawa M; Wu L; Klein-Szanto AJ; Herlyn M; Diehl JA; Katz JP; Pear WS; Seykora JT; Nakagawa H
    Gastroenterology; 2010 Dec; 139(6):2113-23. PubMed ID: 20801121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch and MAML-1 complexation do not detectably alter the DNA binding specificity of the transcription factor CSL.
    Del Bianco C; Vedenko A; Choi SH; Berger MF; Shokri L; Bulyk ML; Blacklow SC
    PLoS One; 2010 Nov; 5(11):e15034. PubMed ID: 21124806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling notch signaling in normal and neoplastic hematopoiesis: global gene expression profiling in response to activated notch expression.
    Ganapati U; Tan HT; Lynch M; Dolezal M; de Vos S; Gasson JC
    Stem Cells; 2007 Aug; 25(8):1872-80. PubMed ID: 17464091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch-independent functions of CSL.
    Johnson JE; Macdonald RJ
    Curr Top Dev Biol; 2011; 97():55-74. PubMed ID: 22074602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and function of the CSL-KyoT2 corepressor complex: a negative regulator of Notch signaling.
    Collins KJ; Yuan Z; Kovall RA
    Structure; 2014 Jan; 22(1):70-81. PubMed ID: 24290140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers.
    Wang H; Zang C; Taing L; Arnett KL; Wong YJ; Pear WS; Blacklow SC; Liu XS; Aster JC
    Proc Natl Acad Sci U S A; 2014 Jan; 111(2):705-10. PubMed ID: 24374627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of CSL (CBF-1, Su(H), Lag-1) mutants reveals differences in signaling mediated by Notch1 and Notch2.
    Yuan Z; Friedmann DR; VanderWielen BD; Collins KJ; Kovall RA
    J Biol Chem; 2012 Oct; 287(42):34904-34916. PubMed ID: 22915591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSL-Associated Corepressor and Coactivator Complexes.
    Oswald F; Kovall RA
    Adv Exp Med Biol; 2018; 1066():279-295. PubMed ID: 30030832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The miR-143/145 cluster is a novel transcriptional target of Jagged-1/Notch signaling in vascular smooth muscle cells.
    Boucher JM; Peterson SM; Urs S; Zhang C; Liaw L
    J Biol Chem; 2011 Aug; 286(32):28312-21. PubMed ID: 21685392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairy-related transcription factors inhibit Notch-induced smooth muscle alpha-actin expression by interfering with Notch intracellular domain/CBF-1 complex interaction with the CBF-1-binding site.
    Tang Y; Urs S; Liaw L
    Circ Res; 2008 Mar; 102(6):661-8. PubMed ID: 18239137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.
    Katoh M; Katoh M
    Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive genomic features indicative for Notch responsiveness.
    Giaimo BD; Friedrich T; Ferrante F; Bartkuhn M; Borggrefe T
    Nucleic Acids Res; 2024 May; 52(9):5179-5194. PubMed ID: 38647081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid translocation gene 16 (MTG16) interacts with Notch transcription complex components to integrate Notch signaling in hematopoietic cell fate specification.
    Engel ME; Nguyen HN; Mariotti J; Hunt A; Hiebert SW
    Mol Cell Biol; 2010 Apr; 30(7):1852-63. PubMed ID: 20123979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional repression in the Notch pathway: thermodynamic characterization of CSL-MINT (Msx2-interacting nuclear target protein) complexes.
    VanderWielen BD; Yuan Z; Friedmann DR; Kovall RA
    J Biol Chem; 2011 Apr; 286(17):14892-902. PubMed ID: 21372128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative dissection of the Notch:CSL interaction: insights into the Notch-mediated transcriptional switch.
    Lubman OY; Ilagan MX; Kopan R; Barrick D
    J Mol Biol; 2007 Jan; 365(3):577-89. PubMed ID: 17070841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis of N1ICD/RBPJ targets in vivo reveals direct transcriptional regulation of Wnt, SHH, and hippo pathway effectors by Notch1.
    Li Y; Hibbs MA; Gard AL; Shylo NA; Yun K
    Stem Cells; 2012 Apr; 30(4):741-52. PubMed ID: 22232070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BEND6 is a nuclear antagonist of Notch signaling during self-renewal of neural stem cells.
    Dai Q; Andreu-Agullo C; Insolera R; Wong LC; Shi SH; Lai EC
    Development; 2013 May; 140(9):1892-902. PubMed ID: 23571214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence.
    Guiu J; Bergen DJ; De Pater E; Islam AB; Ayllón V; Gama-Norton L; Ruiz-Herguido C; González J; López-Bigas N; Menendez P; Dzierzak E; Espinosa L; Bigas A
    J Exp Med; 2014 Nov; 211(12):2411-23. PubMed ID: 25385755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.